Tag: mCRC third-line treatment

Home / mCRC third-line treatment

Categories

Trifluridine and tipiracil with bevacizumab is approved by FDA for previously treated metastatic colorectal cancer

August 2023: For metastatic colorectal cancer (mCRC) that has already been treated with fluoropyrimidine, oxaliplatin, and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS w...
mcrc-third-line-treatment

Scan the code